Brief: MBX Biosciences Announces Executive Leadership Transition To Support The Company’S Next Phase Of Growth
13/07/2026 23:24
BRIEF-MBX Biosciences Announces Executive Leadership Transition To Support The Company’S Next Phase Of Growth July 13 (Reuters) - MBX Biosciences Inc MBX.O:
MBX BIOSCIENCES ANNOUNCES EXECUTIVE LEADERSHIP TRANSITION TO SUPPORT THE COMPANY’S NEXT PHASE OF GROWTH
MBX BIOSCIENCES - APPOINTS STEVE HOERTER AS CHAIRMAN AND CEO
MBX BIOSCIENCES - KENT HAWRYLUK STEPS DOWN AS PRESIDENT, CEO AND BOARD MEMBER
MBX BIOSCIENCES - APPOINTS JOHN SMITHER AS CHIEF FINANCIAL OFFICER
MBX BIOSCIENCES - ALL LEADERSHIP CHANGES EFFECTIVE IMMEDIATELY
Source text: ID:nGNX1hHfhg
Further company coverage: MBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on MBX Biosciences
See all newsU.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC Solutions
MBX Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: MBX Biosciences Announces Executive Leadership Transition To Support The Company’S Next Phase Of Growth
MBX Biosciences falls after executive shakeup
U.S. STOCKS ON THE MOVE-SpaceX, Tesla, Woodside Energy Group